Salesforce Shares Hit 14-Day Losing Streak Amid AI Strategy Doubts
Salesforce stock extended a record losing streak to 14 straight sessions as investors question whether the CRM giant can reinvent itself around AI.
Salesforce is experiencing an unusually prolonged rout in its stock price, with shares declining for a 14th consecutive session — a record losing streak that signals deep-seated investor skepticism about the company's ability to capitalize on the artificial intelligence wave reshaping enterprise software.
The streak is notable not merely for its length but for what it represents: a market verdict on whether a legacy CRM platform, however dominant, can genuinely disrupt its own business model before nimbler AI-native competitors do it for them. Investors are essentially pricing in execution risk — the very real possibility that Salesforce's AI initiatives, however loudly marketed, may not translate into the kind of revenue acceleration Wall Street demands at current valuations.
Read more Ric Edelman: Crypto's Real Growth Story Isn't the Price →
This kind of self-disruption challenge is among the hardest in corporate strategy. Companies that built moats through data lock-in and sprawling sales forces face a fundamental tension when new technology promises to automate or disintermediate the very workflows their products support. For Salesforce, the question is whether its AI tools deepen customer dependency or merely add a veneer of innovation to a maturing platform.
The sustained selloff also reflects a broader recalibration happening across enterprise software stocks, where initial AI enthusiasm has given way to harder questions about monetization timelines, competitive differentiation, and margin impact. Salesforce, as one of the sector's bellwether names, is absorbing that skepticism with particular force.
Whether management can articulate a credible AI growth narrative — and demonstrate early commercial traction — will likely determine whether this losing streak marks a buying opportunity or the beginning of a more structural revaluation. Continue reading at MarketWatch.com
